Result Summary for 113079
|Clinical Study ID:||ROR113079|
|Official Title:||Clinical evaluation of ropinirole IR (immediate release) tablets in patients who are diagnosed with symptomatic restless legs syndrome (RLS) associated with Chronic kidney disease (CKD) managed with haemodialysis (including haemofiltration and haemodiafiltration)|
|Study Indications or Diseases:||
|Trade/Product Name:||Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL|
|Approved Drug Label:||http://www.gsk.com/products.html|
|Results Summary:|| Click
here to download result summary.
The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.